Why drug discovery & development needs fixing for chronic diseases?
The blockbuster model for drug discovery and development in chronic diseases is inefficient and costly. We need a new…
12/10/21
Schizophrenia
We stratified a schizophrenia patient population to identify disease sub-groups and new targets for treatment responsive and resistant groups.
10/12/20
ALS Patient Stratification Analysis
We found 33 novel genes that were strongly associated with ALS and have selected 10 targets of significant interest for drug discovery screening.
9/12/20
Non-T2 (Non-Eosinophilic) Asthma
We revealed clear genetic differences between T2 / non-T2 asthma patients, leading to stratification biomarkers and novel, validated targets for non-T2 asthma.
10/12/20
Sjögren’s Syndrome
Identification of 299 risk-associated genes that are strongly associated with Sjögren’s syndrome.
23/03/21